Block copolymers of ethylene oxide and phenyl glycidyl ether: micellization, gelation, and drug solubilization. 2005

Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
Department of Physics of Condensed Matter, University of Santiago de Compostela, E-15706 Santiago de Compostela, Spain.

Three triblock copolymers of ethylene oxide and phenyl glycidyl ether, type E(m)G(n)E(m), where G = OCH2CH(CH2OC6H5) and E = OCH2CH2, were synthesized and characterized by gel-permeation chromatography, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, and NMR spectroscopy. Their association properties in aqueous solution were investigated by surface tensiometry and light scattering, yielding values of the critical micelle concentration (cmc), the hydrodynamic radius, and the association number. Gel boundaries in concentrated micellar solution were investigated by tube inversion, and for one copolymer, the temperature and frequency dependence of the dynamic moduli served to confirm and extend the phase diagram and to highlight gel properties. Small-angle X-ray scattering was used to investigate gel structure. The overall aim of the work was to define a block copolymer micellar system with better solubilization capacity for poorly soluble aromatic drugs than had been achieved so far by use of block copoly(oxyalkylene)s. Judged by the solubilization of griseofulvin in aqueous solutions of the E(m)G(n)E(m) copolymers, this aim was achieved.

UI MeSH Term Description Entries
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D010647 Phenyl Ethers Ethers that are linked to a benzene ring structure. Diphenyl Oxide,Diphenyl Oxides,Diphenyl Ethers,Ethers, Diphenyl,Ethers, Phenyl,Oxide, Diphenyl,Oxides, Diphenyl
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D005026 Ethylene Glycols An ethylene compound with two hydroxy groups (-OH) located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze. Dihydroxyethanes,Ethanediols,Glycols, Ethylene
D005027 Ethylene Oxide A colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794) Oxirane,Oxide, Ethylene
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D006118 Griseofulvin An antifungal agent used in the treatment of TINEA infections. Fulvicin-U-F,Grifulvin V,Gris-PEG,Grisactin,Grisefuline,Fulvicin U F,FulvicinUF,Gris PEG,GrisPEG
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
December 2012, Journal of colloid and interface science,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
September 2007, The journal of physical chemistry. B,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
January 1999, IARC monographs on the evaluation of carcinogenic risks to humans,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
May 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
April 2023, Polymers,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
September 2007, Expert opinion on drug delivery,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
September 2004, Journal of colloid and interface science,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
January 1983, Contact dermatitis,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
July 2004, Journal of colloid and interface science,
Pablo Taboada, and Gemma Velasquez, and Silvia Barbosa, and Valeria Castelletto, and S Keith Nixon, and Zhuo Yang, and Frank Heatley, and Ian W Hamley, and Marianne Ashford, and Victor Mosquera, and David Attwood, and Colin Booth
August 2017, Polymers,
Copied contents to your clipboard!